Two targets, PRKCA and RHOA proteins, and four signaling pathways, including the mTOR signaling pathway, Type II diabetes mellitus, and Ras and Rap1 signaling pathway, were predicted and considered as key nodes and pathways through which Forsythiaside ameliorated DKD podocytopathy. Here, PRKCA is linked to diabetic kidney disease.